Dow Today: Johnson & Johnson (JNJ) Leads The Day Higher, Bank Of America Corporation (BAC) Lags

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

The Dow Jones Industrial Average ( ^DJI) is trading down 114.0 points (-0.8%) at 14,642 as of Wednesday, Apr 17, 2013, 10:10 a.m. ET. During this time, 177 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 591.2 million. The NYSE advances/declines ratio sits at 544 issues advancing vs. 2,298 declining with 104 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Dow component leading the way higher looks to be Johnson & Johnson (NYSE: JNJ), which is sporting a 65-cent gain (+0.8%) bringing the stock to $84.09. Volume for Johnson & Johnson currently sits at 2.8 million shares traded vs. an average daily trading volume of 9.7 million shares.

Johnson & Johnson has a market cap of $228.55 billion and is part of the health care sector and drugs industry. Shares are up 19% year to date as of Tuesday's close. The stock's dividend yield sits at 3%.

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The company has a P/E ratio of 21.2, above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Johnson & Johnson as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.

Holding back the Dow today is Bank of America Corporation (NYSE: BAC), which is lagging the broader Dow index with a 47-cent decline (-3.8%) bringing the stock to $11.81. This single loss is lowering the Dow Jones Industrial Average by 3.56 points or roughly accounting for 3.1% of the Dow's overall loss. Volume for Bank of America Corporation currently sits at 95 million shares traded vs. an average daily trading volume of 149.4 million shares.

Bank of America Corporation has a market cap of $129.65 billion and is part of the financial sector and banking industry. Shares are up 5.8% year to date as of Tuesday's close. The stock's dividend yield sits at 0.3%.

Bank of America Corporation, through its subsidiaries, provides various banking and financial products and services for individual consumers, small and middle market businesses, institutional investors, corporations, and governments in the United States and internationally. The company has a P/E ratio of 47.9, above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Bank of America Corporation as a hold. The company's strengths can be seen in multiple areas, such as its expanding profit margins, solid stock price performance and notable return on equity. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, generally higher debt management risk and weak operating cash flow.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE.
null

If you liked this article you might like

Roku, Nucana and Other IPOs That Should Be on Your Radar in 2017

Some of Trump's NFL Owner Friends Side With Players in Dispute With President

The Best Companies for Women

Crazy Weak U.S. Dollar Will Make These 10 Companies Huge Winners

Cramer: Goldman's Downgrade Of J&J Is 'Questionable'